VulnerabilityModified
CVE-2020-16247
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.
HIGH 7.1EPSS 0.36%
Does this matter?
High impact if exploited, but EPSS currently rates exploitation as unlikely (0.36%). Schedule it in the normal patch cycle and watch for a rise in EPSS or a public exploit.
Description
Philips Clinical Collaboration Platform, Versions 12.2.1 and prior, exposes a resource to the wrong control sphere, providing unintended actors with inappropriate access to the resource.
- CVSS 3.1
- 7.1 HIGHCVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:N
- EPSS
- 0.36% probability · 29th percentile
- CISA KEV
- Not listed
- Weakness
- CWE-16, CWE-668
- Affected
- philips/clinical collaboration platform
- Source
- ics-cert@hq.dhs.gov
References
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party Advisory, US Government Resource
- https://www.philips.com/a-w/security/security-advisories/product-security-2020.html#2020_archive
- https://us-cert.cisa.gov/ics/advisories/icsma-20-261-01Third Party Advisory, US Government Resource
Source: NVD record, EPSS from FIRST.org, KEV from CISA. Refreshed daily.